Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
- PMID: 1808224
- DOI: 10.1016/0168-8278(91)90074-l
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
Abstract
Since the hepatitis B virus is noncytopathic, it is generally believed that the individual specific immune response determines the course of infection. The lack of data about hepatitis B virus-specific T-cell reactions in acute infection led us to investigate the specific cellular immune response of infected individuals in terms of proliferation, and gamma-interferon and lymphotoxin production. Our results demonstrate that peripheral blood mononuclear cells (PBMNC) from patients with acute and chronic hepatitis B respond weakly to HBsAg. In contrast, patients with acute hepatitis show a vigorous response to the nucleocapsid antigen (HBcAg) in terms of proliferation and lymphokine production, while only few chronic virus carriers gave a proliferative response. Either of the antigens could activate lymphocytes to produce gamma-interferon and lymphotoxin, cytokines which may modulate antiviral immune response.
Similar articles
-
HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.J Hepatol. 1998 Jan;28(1):8-16. doi: 10.1016/s0168-8278(98)80196-7. J Hepatol. 1998. PMID: 9537868
-
Gamma-interferon production in response to hepatitis B core protein and its synthetic peptides in patients with chronic hepatitis B virus infection.Digestion. 1990;47(3):149-55. doi: 10.1159/000200490. Digestion. 1990. PMID: 1707382
-
Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.Biochemistry (Mosc). 1998 May;63(5):551-8. Biochemistry (Mosc). 1998. PMID: 9632891
-
Immunology of hepatitis B virus infection.Br Med Bull. 1990 Apr;46(2):354-67. doi: 10.1093/oxfordjournals.bmb.a072403. Br Med Bull. 1990. PMID: 2198991 Review.
-
Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.Immunol Commun. 1978;7(4):371-82. doi: 10.3109/08820137809047623. Immunol Commun. 1978. PMID: 352919 Review.
Cited by
-
Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B.Virol J. 2011 Jun 3;8:270. doi: 10.1186/1743-422X-8-270. Virol J. 2011. PMID: 21639870 Free PMC article.
-
Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.World J Gastroenterol. 2010 Dec 28;16(48):6145-50. doi: 10.3748/wjg.v16.i48.6145. World J Gastroenterol. 2010. PMID: 21182232 Free PMC article.
-
Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model.PLoS One. 2016 Mar 17;11(3):e0151717. doi: 10.1371/journal.pone.0151717. eCollection 2016. PLoS One. 2016. PMID: 26986976 Free PMC article.
-
Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures.Clin Transl Immunology. 2021 Jan 15;10(1):e1232. doi: 10.1002/cti2.1232. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33489122 Free PMC article. Review.
-
Immunopathogenesis of viral hepatitis.Clin Rev Allergy Immunol. 2000 Apr;18(2):141-66. doi: 10.1385/CRIAI:18:2:141. Clin Rev Allergy Immunol. 2000. PMID: 10944703 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical